From eligibility check to prescription delivery — the complete walkthrough for patients navigating telehealth, insurance, self-pay, and the new pricing landscape.
More than 30 million Americans — roughly 12.4% of the adult population — are now using GLP-1 medications for weight loss. Two years ago, getting a prescription required navigating insurance denials, pharmacy shortages, and $1,000+ monthly costs. In 2026, the process is faster, cheaper, and more accessible than ever. Here's exactly how it works.
The FDA-approved eligibility criteria for prescription weight loss medications haven't changed, though the landscape of who can access them has expanded considerably:
Some medications have specific eligibility requirements. Tirzepatide (Zepbound) also requires a BMI of 30+ or 27+ with comorbidities. Phentermine requires a BMI of 30+ or 27+ with risk factors. Metformin (off-label for weight loss) has no formal weight-based eligibility since it's prescribed primarily for blood sugar management.
BMI is an imperfect screening tool — it misclassifies athletes, varies by ethnicity, and ignores body composition. Some providers assess patients more holistically using waist-to-hip ratio, metabolic health markers, and body composition data. See our guide: Beyond BMI: Better Ways to Know If You Need Weight Loss Treatment.
You have three main routes to a prescription in 2026:
Telehealth platforms (fastest — often same-day prescriptions): Online consultation with a licensed provider, typically via video or asynchronous questionnaire. Medication ships directly to your door. Best for straightforward cases. Most platforms handle everything — consultation, prescription, pharmacy, and shipping — in one workflow.
Primary care physician: Your existing doctor can prescribe weight loss medications. Pros: they know your full medical history. Cons: may require a scheduled appointment, some PCPs aren't comfortable prescribing GLP-1s, and they may refer you to a specialist instead.
Obesity medicine specialist: Board-certified obesity medicine physicians (ABOM) offer the most comprehensive clinical approach. Best for complex cases — multiple medications, prior bariatric surgery, severe metabolic conditions. May be covered by insurance if referred by your PCP.
One of the broadest telehealth platforms available. See a licensed provider for a weight loss medication evaluation, often within 24–48 hours.
Book a Consultation →Whether telehealth or in-person, have the following ready:
Telehealth platforms typically collect this information through an online questionnaire before your consultation. The more complete your answers, the faster the process.
Your provider will assess:
Some telehealth platforms accept recent lab results from your PCP. Others partner with lab networks (Quest, Labcorp) so you can get blood work drawn locally before or after your consultation.
Your provider will recommend a medication based on your clinical profile, goals, and budget. The primary considerations:
The 2026 pricing landscape offers multiple pathways:
Insurance: Roughly 55% of large employers now cover GLP-1s for obesity, though some insurers (like Blue Cross Blue Shield of Massachusetts) have pulled coverage in 2026. Check your formulary — prior authorization is almost always required, and step therapy (trying cheaper drugs first) is common.
Manufacturer self-pay programs: NovoCare (Wegovy injection $349/mo, pill $149–299/mo), LillyDirect (Zepbound $199–449/mo), TrumpRx.gov (connects patients to manufacturer discounts, ~$250–350/mo injectable, $149 pill).
Telehealth platforms: All-inclusive pricing (consultation + medication + shipping) typically ranges from $149–400/month for GLP-1 programs.
HSA/FSA: Weight loss medications prescribed for obesity treatment qualify as eligible medical expenses. See our complete HSA/FSA guide.
Medicare: The Medicare GLP-1 Bridge launches July 2026 with a $50/month copay for eligible beneficiaries. The full BALANCE Model Part D coverage begins January 2027. See our Medicare GLP-1 coverage guide.
Complete the online evaluation, consult with a licensed provider, and have your medication shipped directly. Transparent pricing with no surprises.
Start Your Evaluation →All GLP-1 medications start at a low dose and titrate up gradually — this minimizes the nausea and GI side effects that are most common in the first 4–8 weeks. Your provider will schedule a follow-up (usually at 4 weeks) to assess tolerability and adjust dosing.
Expect to be in regular contact with your provider throughout the first 3–6 months. Most telehealth platforms include messaging access to your care team. In-person patients typically schedule visits every 4–12 weeks during titration.
The critical milestone: if you haven't lost at least 5% of your body weight by 12 weeks on the maintenance dose, your provider should reassess the treatment plan — this may include switching medications, adjusting the dose, or evaluating adherence and lifestyle factors.
Choose telehealth if: You want speed and convenience, your case is straightforward (no complex comorbidities), you're comfortable with virtual consultations, and you want all-inclusive pricing.
Choose in-person if: You have multiple chronic conditions requiring coordination, you want comprehensive lab work and physical examination, you prefer face-to-face medical relationships, or your insurance covers in-person visits but not telehealth.
Licensed providers, convenient online consultations, and medication delivered to your door. See if you qualify today.
Check Eligibility →